Page last updated: 2024-08-23

fomesafen and Congenital Myasthenia

fomesafen has been researched along with Congenital Myasthenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Almodovar, JL; Bansagi, B; Hasan, BA; Herrmann, DN; Horvath, R; Littleton, JT; Lochmüller, H; Lofra, RM; Logigian, EL; Sowden, JE; Whittaker, RG; Zuchner, S	1

Other Studies

1 other study(ies) available for fomesafen and Congenital Myasthenia

Article	Year
Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome. Neurology, 2015, Dec-01, Volume: 85, Issue:22 Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Amifampridine; Child; Electrophysiological Phenomena; Female; Humans; Male; Middle Aged; Mutation; Myasthenic Syndromes, Congenital; Potassium Channel Blockers; Pyridostigmine Bromide; Reflex; Synaptic Transmission; Synaptotagmin II; Young Adult	2015

Article

Year

Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.

Neurology, 2015, Dec-01, Volume: 85, Issue:22

Topics: 4-Aminopyridine; Adolescent; Adult; Aged; Amifampridine; Child; Electrophysiological Phenomena; Female; Humans; Male; Middle Aged; Mutation; Myasthenic Syndromes, Congenital; Potassium Channel Blockers; Pyridostigmine Bromide; Reflex; Synaptic Transmission; Synaptotagmin II; Young Adult

2015